Cargando…
E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma.
Expression of the calcium-dependent cell-cell adhesion molecule E-cadherin has been examined in 187 primary breast carcinomas using an immunohistochemical technique. The pattern and extent of reactivity has been correlated with clinicopathological data including tumour type, grade and lymph node sta...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075942/ https://www.ncbi.nlm.nih.gov/pubmed/8883410 |
_version_ | 1782138096200974336 |
---|---|
author | Jones, J. L. Royall, J. E. Walker, R. A. |
author_facet | Jones, J. L. Royall, J. E. Walker, R. A. |
author_sort | Jones, J. L. |
collection | PubMed |
description | Expression of the calcium-dependent cell-cell adhesion molecule E-cadherin has been examined in 187 primary breast carcinomas using an immunohistochemical technique. The pattern and extent of reactivity has been correlated with clinicopathological data including tumour type, grade and lymph node status and with other prognostic parameters including oestrogen receptor (ER) status, expression of c-erbB-2, pS2 protein and epidermal growth factor receptor (EGFR). Two patterns of E-cadherin staining were observed in carcinomas, membrane reactivity and a diffuse cytoplasmic staining. A marked difference in expression of E-cadherin was observed between infiltrating lobular carcinomas (ILC) and infiltrating ductal carcinomas (IDC), the former showing complete loss of membrane staining, whereas 93% of IDC retained some level of expression. In IDC reactivity was not related to tumour grade but there was a significant association between reduced membrane levels of E-cadherin and the presence of lymph node metastasis, and a highly significant correlation between the presence of cytoplasmic E-cadherin and metastasis. A significant relationship was also demonstrated between reduced E-cadherin reactivity and expression of EGFR. These findings emphasise the complexity of control of E-cadherin in breast carcinomas and provide evidence of a link between membrane signalling pathways and modulation of E-cadherin expression. IMAGES: |
format | Text |
id | pubmed-2075942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20759422009-09-10 E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Jones, J. L. Royall, J. E. Walker, R. A. Br J Cancer Research Article Expression of the calcium-dependent cell-cell adhesion molecule E-cadherin has been examined in 187 primary breast carcinomas using an immunohistochemical technique. The pattern and extent of reactivity has been correlated with clinicopathological data including tumour type, grade and lymph node status and with other prognostic parameters including oestrogen receptor (ER) status, expression of c-erbB-2, pS2 protein and epidermal growth factor receptor (EGFR). Two patterns of E-cadherin staining were observed in carcinomas, membrane reactivity and a diffuse cytoplasmic staining. A marked difference in expression of E-cadherin was observed between infiltrating lobular carcinomas (ILC) and infiltrating ductal carcinomas (IDC), the former showing complete loss of membrane staining, whereas 93% of IDC retained some level of expression. In IDC reactivity was not related to tumour grade but there was a significant association between reduced membrane levels of E-cadherin and the presence of lymph node metastasis, and a highly significant correlation between the presence of cytoplasmic E-cadherin and metastasis. A significant relationship was also demonstrated between reduced E-cadherin reactivity and expression of EGFR. These findings emphasise the complexity of control of E-cadherin in breast carcinomas and provide evidence of a link between membrane signalling pathways and modulation of E-cadherin expression. IMAGES: Nature Publishing Group 1996-10 /pmc/articles/PMC2075942/ /pubmed/8883410 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Jones, J. L. Royall, J. E. Walker, R. A. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. |
title | E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. |
title_full | E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. |
title_fullStr | E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. |
title_full_unstemmed | E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. |
title_short | E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. |
title_sort | e-cadherin relates to egfr expression and lymph node metastasis in primary breast carcinoma. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075942/ https://www.ncbi.nlm.nih.gov/pubmed/8883410 |
work_keys_str_mv | AT jonesjl ecadherinrelatestoegfrexpressionandlymphnodemetastasisinprimarybreastcarcinoma AT royallje ecadherinrelatestoegfrexpressionandlymphnodemetastasisinprimarybreastcarcinoma AT walkerra ecadherinrelatestoegfrexpressionandlymphnodemetastasisinprimarybreastcarcinoma |